scholarly journals A FILTERABLE VIRUS PRESENT IN THE SUBMAXILLARY GLANDS OF GUINEA PIGS

1926 ◽  
Vol 44 (6) ◽  
pp. 855-873 ◽  
Author(s):  
Rufus Cole ◽  
Ann G. Kuttner

In the lesions of herpes simplex and similar conditions due to filterable viruses, cells are present which show characteristic alterations, particularly in the nucleus. The nucleus of these cells contains a mass which stains with acid dyes. Surrounding this mass is a clear space or halo, within which there are large granules staining with basic stains. These cells are little if at all enlarged. In a few human cases, especially in infants, enlarged cells have been found which contain nuclei showing changes similar to those seen in the abnormal cells of herpes simplex. In the ducts of the submaxillary glands of guinea pigs, Jackson observed structures which she considered to be protozoan parasites. Our own studies indicate, however, that these structures are greatly swollen epithelial cells with nuclei having the same characters as the nuclei of the atypical cells in the lesions of herpes simplex. These cells are usually surrounded by a mononuclear cellular reaction. They were found in 84 per cent of the full grown guinea pigs examined but they were present in only three of forty-three young guinea pigs less than 1 month old. The resemblance of these cells, except as regards size, to the atypical cells present in lesions due to filterable viruses suggested that they also may be the result of an infection with a similar agent. That they are usually not present in guinea pigs less than 1 month old indicates that natural infection usually occurs after this period. Experiments were therefore undertaken to determine whether or not an infective agent is concerned in this condition and if so to learn something of its nature. When an emulsion of the submaxillary glands of full grown guinea pigs is injected into the brains of young guinea pigs the animals have fever and exhibit symptoms of cerebral irritation. They usually die in 5 to 7 days and in sections of the brain a diffuse subacute meningitis is found. In the exudate there are large numbers of cells having all the characteristics of the abnormal cells of herpes simplex. Similar cells are present in the lesions resulting from the injection of the same emulsion into the testicle, lung, tongue, and submaxillary glands of young guinea pigs. In none of these lesions, however, are the cells greatly enlarged as they are in the lesions in old guinea pigs. These results support the view that the lesion in the submaxillary gland of old guinea pigs is due to an infective agent. Attempts were therefore made to transmit this agent through a series of young guinea pigs. When the injections were all made into the same organ all the experiments but one gave negative results, but when the site of injection was changed at each transfer it was possible in a number of instances to reproduce the lesions through two animals in series and in one experiment through three animals in series. By modifying the technique, efforts were made to transmit the infection indefinitely but these attempts were unsuccessful. No explanation can be offered for this failure. Studies made to determine some of the properties of the infective agent have shown that it is destroyed by heating at 54° for 1 hour, and that it is not injured by preservation in 50 per cent glycerol for as long as 11 days. After the material had remained in 50 per cent glycerol for 28 days, however, it was found to be no longer infective. The infective agent was not held back by a Berkefeld N filter which was impermeable to bacteria. It seems probable therefore that the infective agent belongs in the group of filterable viruses, though further work will be necessary to learn more of its exact nature. These observations present additional evidence that the presence of cells with nuclear inclusions in any lesion indicates that the injury is probably due to an infective agent belonging in the group of filterable viruses.

1927 ◽  
Vol 46 (6) ◽  
pp. 935-956 ◽  
Author(s):  
Ann G. Kuttner

1. It has been shown that the guinea pig virus localizes in the submaxillary glands of young guinea pigs following subcutaneous, intraperitoneal, or intravenous injection of active material, and that the specific lesion is demonstrable in the glands in 12 to 15 days. When an active infection of the gland has been produced in this way, the guinea pigs are refractory to intracerebral inoculation of the virus. 2. No lesion develops in the submaxillary glands of young guinea pigs injected subcutaneously with guinea pig virus which has been inactivated by heat. Young guinea pigs which have received injections of heat-killed virus do not become refractory to intracerebral inoculation of the virus. 3. When young guinea pigs from which both submaxillary glands have been removed are injected subcutaneously with active virus, the virus localizes in the parotid gland, and the animals become refractory to intracerebral inoculation. 4. It has been impossible to demonstrate virucidal properties in the sera of adult guinea pigs which have become spontaneously infected with the virus, or in the sera of young guinea pigs which have been artificially rendered refractory to intracerebral inoculation. 5. It has been possible to transmit the virus from guinea pig to guinea pig continuously in series through seven animals by direct inoculation from submaxillary gland to submaxillary gland. 6. The fact that the virus regularly localizes in the submaxillary glands following subcutaneous inoculation has been utilized in passing the virus from guinea pig to guinea pig. 2 weeks after the subcutaneous inoculation of the virus into young guinea pigs, the active agent was present in the submaxillary glands. Emulsions of the submaxillary glands of these animals were then used for the subcutaneous injection of another group of young guinea pigs. In this way the virus was transmitted continuously from skin to submaxillary gland through a series of seven animals.


2001 ◽  
Vol 183 (6) ◽  
pp. 844-849 ◽  
Author(s):  
David I. Bernstein ◽  
Christopher J. Harrison ◽  
Mark A. Tomai ◽  
Richard L Miller

Chemotherapy ◽  
1989 ◽  
Vol 35 (1) ◽  
pp. 58-63 ◽  
Author(s):  
Pilar Vilas ◽  
Conceptión Perez ◽  
Sara Perez ◽  
Dolores G. Villalon ◽  
Angel Garcia Gancedo ◽  
...  

Virology ◽  
2019 ◽  
Vol 526 ◽  
pp. 180-188 ◽  
Author(s):  
Nigel Bourne ◽  
Brianne N. Banasik ◽  
Clarice L. Perry ◽  
Aaron L. Miller ◽  
Mellodee White ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Michael P. Leviton ◽  
Juan C. Lacayo ◽  
K. Yeon Choi ◽  
Nelmary Hernandez-Alvarado ◽  
Andrew Wey ◽  
...  

Development of a vaccine against congenital cytomegalovirus (CMV) infection is a public health priority, but CMVs encode immune evasion genes that complicate live virus vaccine design. To resolve this problem, this study employed guanosyl phosphoribosyl transferase (gpt) mutagenesis to generate a recombinant guinea pig CMV (GPCMV) with a knockout of a viral chemokine gene, GPCMV MIP (gp1). MIP deletion virus replicated with wild-type kinetics in cell culture but was attenuated in nonpregnant guinea pigs, demonstrating reduced viremia and reduced inflammation and histopathology (compared to a control virus with an intact GPCMV MIP gene) following footpad inoculation. In spite of attenuation, the vaccine was immunogenic, eliciting antibody responses comparable to those observed in natural infection. To assess its protective potential as a vaccine, either recombinant virus or placebo was used to immunize seronegative female guinea pigs. Dams were challenged in the early 3rd trimester with salivary gland-adapted GPCMV. Immunization protected against DNAemia (1/15 in vaccine group versus 12/13 in the control group,P<0.01). Mean birth weights were significantly higher in pups born to vaccinated dams compared to controls (98.7 g versus 71.2 g,P<0.01). Vaccination reduced pup mortality, from 35/50 (70%) in controls to 8/52 (15%) in the immunization group. Congenital GPCMV infection was also reduced, from 35/50 (70%) in controls to 9/52 (17%) in the vaccine group (P<0.0001). We conclude that deletion of an immune modulation gene can attenuate the pathogenicity of GPCMV while resulting in a viral vaccine that retains immunogenicity and demonstrates efficacy against congenital infection and disease.


Vaccine ◽  
2018 ◽  
Vol 36 (20) ◽  
pp. 2842-2849 ◽  
Author(s):  
Brent A. Stanfield ◽  
Paul J.F. Rider ◽  
John Caskey ◽  
Fabio Del Piero ◽  
Konstantin G. Kousoulas

Sign in / Sign up

Export Citation Format

Share Document